Instil Bio, Inc. (TIL) has a consensus analyst rating of Hold, based on 7 analysts covering the stock. Of those, 3 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for TIL is $7.00, representing a -17.1% downside from the current price of $8.44. Price targets range from a low of $7.00 to a high of $7.00.
